Inventor
VOJKOVSKY TOMAS
US23 patents
⚠️ This page may combine multiple inventors who share the name “VOJKOVSKY TOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SUGEN INC
10 patentsUS6573293B2Jun 3, 2003
Pyrrole substituted 2-indolinone protein kinase inhibitors
SUGEN INC174 citations98
US6653308B2Nov 25, 2003
3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
SUGEN INC75 citations96
US7125905B2Oct 24, 2006
Pyrrole substituted 2-indolinone protein kinase inhibitors
SUGEN INC59 citations95
US7572924B2Aug 11, 2009
Pyrrole substituted 2-indolinone protein kinase inhibitors
SUGEN INC25 citations92
US6642232B2Nov 4, 2003
3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
SUGEN INC13 citations81
US6797725B2Sep 28, 2004
Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
SUGEN INC12 citations73
US7053114B2May 30, 2006
Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
SUGEN INC5 citations62
US7037909B2May 2, 2006
Tetracyclic compounds as c-Met inhibitors
SUGEN INC5 citations61
US7582756B2Sep 1, 2009
3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
SUGEN INC0 citations51
US7122548B2Oct 17, 2006
Triazolotriazine compounds and uses thereof
SUGEN INC0 citations40
BOLD THERAPEUTICS INC
4 patentsUS11040993B2Jun 22, 2021
Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof
BOLD THERAPEUTICS INC4 citations82
US10611787B2Apr 7, 2020
Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof
BOLD THERAPEUTICS INC4 citations82
US11739111B2Aug 29, 2023
Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof
BOLD THERAPEUTICS INC2 citations71
US12415825B2Sep 16, 2025
Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof
BOLD THERAPEUTICS INC0 citations61